Human Immunodeficiency Virus
328
21
30
244
Key Insights
Highlights
Success Rate
92% trial completion (above average)
Published Results
98 trials with published results (30%)
Research Maturity
244 completed trials (74% of total)
Clinical Risk Assessment
Based on trial outcomes
Low Risk
Score: 27/100
6.1%
20 terminated out of 328 trials
92.4%
+5.8% vs benchmark
18%
59 trials in Phase 3/4
40%
98 of 244 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 244 completed trials
Clinical Trials (328)
The Eswatini PRISM Study on Adolescents Living With HIV
Molecular Characterization of Viral-associated Tumors, Tumors Occurring in the Setting of HIV or Other Immune Disorders and Castleman Disease
Tissue Drug Levels of HIV Medications
Problems With Immune Recovery in the Gut Tissue
Improving TelePrEP Initiation and Retention Outcomes in the US: The MISTR+ Study
A Savings Intervention to Reduce Men's Engagement in HIV Risk Behaviors
PositiveLinks for Youth (PL4Y) for Texas
Cytotoxic T Lymphocytes in Treating Patients With Malignancies With BK and/or JC Virus
The Prevalence of Oral HPV Infection and Oral Lesions in People Living With HIV
Acceptability and Feasibility of Combination Treatment for Cervical Precancer Among South African Women Living With HIV
First in Human Study of TLC-ART 101 (ACTU 2001)
Anal High-risk HPV, HSIL, and Microbiome Among Hispanic Peoples Living With HIV (PLWH)
Use of ACU-D1 in HPV Associated Vulvar and Perianal Lesions in People With HIV
The Happy Older Latinos Are Active (HOLA) Health Promotion Study in HIV-Infected Latino Men
Increasing PrEP Use in High-Risk Social Networks of African-American MSM in Underserved Low-Risk Cities
Impact of HIV-1 and Aging on Mucosal Vaccine Responses
Delivery Optimization for Pre-Exposure Prophylaxis (DO PrEP) Study
Harm Reduction in HIV Primary Care for PLWH Who Use Drugs
Lenacapavir Intensification to Disrupt HIV Reservoirs in Virologically Suppressed People With HIV Receiving Antiretroviral Therapy
Liver Fibrosis in Zambian HIV-HBV Co-infected Patients